TNON - Tenon Medical Inc

TNON - Tenon Medical Inc

https://www.tenonmed.com

Momentum: Bearish

Recent News

Powered by Alpha Vantage

Tenon Medical Revenue Falls 37 Percent

Motley Fool • 1 month ago • score: 0.42

Tenon Medical ( NASDAQ:TNON ) reported results for the fiscal second quarter ended June 30, 2025, on August 6, 2025, emphasizing the completed CyVantage acquisition, a 29% year-over-year drop in operating expenses, and a 37.4% year-over-year revenue decline to $564,000.

Why Tenon Medical ( TNON ) Shares Are Getting Hammered - Tenon Medical ( NASDAQ:TNON )

Benzinga • 5 months, 2 weeks ago • score: 0.34

Tenon Medical shares are trading lower by 27.9% during Wednesday's session. The company announced pricing of $2.5 million registered direct offering at $2.00. Pelosi's latest AI pick skyrocketed 169% in just one month. Click here to discover the next stock our government trade tracker is ...

What's Going On With Tenon Medical Shares Tuesday? - Tenon Medical ( NASDAQ:TNON )

Benzinga • 5 months, 3 weeks ago • score: 0.15

The FDA granted 510 ( k ) clearance for an expanded application of the company's Catamaran Sacroiliac Joint Fusion System. Through the new clearance, the FDA recognized the system's potential to augment spinal fusion.

What's Going On With Tenon Medical Stock Tuesday? - Tenon Medical ( NASDAQ:TNON )

Benzinga • 6 months ago • score: 0.50

The company received approval for two additional patents from the European Patent Office. The patents are directed at the company's new Catamaran Sacroiliac Joint Fixation Device. The new Benzinga Rankings show you exactly how stocks stack up-scoring them across five key factors that matter most ...

Interval:

EMA1: EMA2:

AI Tools

Key Metrics

Trend: Downtrend

Source: Snapshot

Tenon Medical, Inc., a medical device company, develops surgical implant systems to optimize sacroiliac joint fixation/fusion surgery and outcomes. The company is headquartered in Los Gatos, California.

52W High

$15.79

52W Low

$0.85

MA Status:

50D: Below 200D: Below

Beta (~1 neutral, <0.9 lower risk)

1.26

Valuation

Attractive

As of 2025-06-30 (Overview)

Trailing P/E (<15 better)

0.21

Forward P/E (<15 better)

N/A

EV/EBITDA (<8 favorable)

-0.13

EV/Revenue (<3 favorable)

2.26

P/S (TTM) (<3 favorable)

3.56

P/B (<3 favorable)

3.54

Ownership

Retail‑heavy

Source: Overview

Insiders (1–5% typical)

14.47%

Institutions (25–75% balanced)

1.40%

Shares Outstanding

8,879,200

Float

8,230,600

Dividend Yield (2–6% sweet spot)

N/A

Ex‑Dividend Date

N/A

Income & Growth

Profitability: Weak

As of 2025-06-30 (Overview)

Revenue (TTM)

2,947,000

Gross Profit (TTM)

1,339,000

EPS (TTM)

5.52

Profit Margin (>10% good)

N/A

Operating Margin (TTM) (higher better)

-5.07%

ROE (TTM) (>15% strong)

-3.36%

EPS YoY (Quarterly) (>10% good)

N/A

Revenue YoY (Quarterly) (>8% good)

-0.37

Momentum

Bearish momentum

Value

-0.0411

Previous

-0.0419

Trend

Rising

Signal Cross

No cross

As of

Sep. 12, 2025